Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Neurosurgical approach.

Moliterno JA, Patel TR, Piepmeier JM.

Cancer J. 2012 Jan-Feb;18(1):20-5. doi: 10.1097/PPO.0b013e3183243f6e3. Review.

PMID:
22290253
2.
3.

Awake surgery for WHO Grade II gliomas within "noneloquent" areas in the left dominant hemisphere: toward a "supratotal" resection. Clinical article.

Yordanova YN, Moritz-Gasser S, Duffau H.

J Neurosurg. 2011 Aug;115(2):232-9. doi: 10.3171/2011.3.JNS101333. Epub 2011 May 6.

PMID:
21548750
4.

Low field intraoperative MRI-guided surgery of gliomas: a single center experience.

Senft C, Franz K, Ulrich CT, Bink A, Szelényi A, Gasser T, Seifert V.

Clin Neurol Neurosurg. 2010 Apr;112(3):237-43. doi: 10.1016/j.clineuro.2009.12.003. Epub 2009 Dec 24.

PMID:
20036049
5.

[Clinical analysis of the fatal cases of adult malignant gliomas after aggressive treatment].

Takamura Y, Ibayashi Y, Morimoto S, Tanabe S, Hashi K.

No Shinkei Geka. 1994 Mar;22(3):207-13. Japanese.

PMID:
8133960
6.

Postoperative epilepsy in patients undergoing craniotomy for glioblastoma multiforme.

Telfeian AE, Philips MF, Crino PB, Judy KD.

J Exp Clin Cancer Res. 2001 Mar;20(1):5-10.

PMID:
11370829
7.

Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.

Marina O, Suh JH, Reddy CA, Barnett GH, Vogelbaum MA, Peereboom DM, Stevens GH, Elinzano H, Chao ST.

J Neurosurg. 2011 Aug;115(2):220-9. doi: 10.3171/2011.3.JNS10495. Epub 2011 May 6.

PMID:
21548745
8.

Effects of iodine-125 brachytherapy on the proliferative capacity and histopathological features of glioblastoma recurring after initial therapy.

Siddiqi SN, Provias J, Laperriere N, Bernstein M.

Neurosurgery. 1997 May;40(5):910-7; discussion 917-8.

PMID:
9149248
9.

Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients.

Clarke JW, Chang EL, Levin VA, Mayr NA, Hong E, Cavaliere R, Lo SS.

Expert Rev Anticancer Ther. 2008 May;8(5):733-41. doi: 10.1586/14737140.8.5.733. Review. Erratum in: Expert Rev Anticancer Ther. 2011 Feb;11(2):323-4.

PMID:
18471046
10.

Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach.

Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y.

J Neurooncol. 1994;21(2):177-85.

PMID:
7861194
11.
12.

Long-term survival in a patient with supratentorial glioblastoma: clinical considerations.

Cervoni L, Celli P, Salvati M.

Ital J Neurol Sci. 1998 Aug;19(4):221-4.

PMID:
10933461
13.

[Intraoperative magnetic resonance tomography for control of extent of neurosurgical operations].

Knauth M, Wirtz CR, Tronnier VM, Staubert A, Kunze S, Sartor K.

Radiologe. 1998 Mar;38(3):218-24. German.

PMID:
9577867
14.

Intraoperative radiation therapy for malignant glioma.

Sakai N, Yamada H, Andoh T, Hirata T, Nishimura Y, Miwa Y, Shimizu K, Yanagawa S.

Neurol Med Chir (Tokyo). 1991 Nov;31(11):702-7.

15.

Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas.

Goodman JH, Yang W, Barth RF, Gao Z, Boesel CP, Staubus AE, Gupta N, Gahbauer RA, Adams DM, Gibson CR, Ferketich AK, Moeschberger ML, Soloway AH, Carpenter DE, Albertson BJ, Bauer WF, Zhang MZ, Wang CC.

Neurosurgery. 2000 Sep;47(3):608-21; discussion 621-2.

PMID:
10981748
16.

Survival and functional status after resection of recurrent glioblastoma multiforme.

Barker FG 2nd, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB.

Neurosurgery. 1998 Apr;42(4):709-20; discussion 720-3.

PMID:
9574634
17.

Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.

Chen AM, Chang S, Pouliot J, Sneed PK, Prados MD, Lamborn KR, Malec MK, McDermott MW, Berger MS, Larson DA.

Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):825-30. Epub 2007 May 23.

PMID:
17512132
18.

Functional and molecular characterization of glioblastoma multiforme-derived cancer stem cells.

Tomuleasa C, Soritau O, Rus-Ciuca D, Ioani H, Susman S, Petrescu M, Timis T, Cernea D, Kacso G, Irimie A, Florian IS.

J BUON. 2010 Jul-Sep;15(3):583-91.

PMID:
20941832
19.

Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.

Attenello FJ, Mukherjee D, Datoo G, McGirt MJ, Bohan E, Weingart JD, Olivi A, Quinones-Hinojosa A, Brem H.

Ann Surg Oncol. 2008 Oct;15(10):2887-93. doi: 10.1245/s10434-008-0048-2. Epub 2008 Jul 18.

PMID:
18636295
20.

Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme.

Patel S, Breneman JC, Warnick RE, Albright RE Jr, Tobler WD, van Loveren HR, Tew JM Jr.

Neurosurgery. 2000 May;46(5):1123-8; discussion 1128-30.

PMID:
10807244

Supplemental Content

Support Center